Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT00943917 · COMPLETED

Trial details

NCT number: NCT00943917
Sponsor: Intarcia Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2009-08-01
Primary completion: 2010-08-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.